Samantha Semenkow
Stock Analyst at Citi
(0.40)
# 4,524
Out of 5,136 analysts
238
Total ratings
42.2%
Success rate
-4.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology | Maintained: Buy | $12 → $11 | $1.88 | +485.11% | 15 | Nov 17, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $19 → $15 | $2.87 | +422.65% | 6 | Nov 12, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,232 | $950.95 | +29.55% | 24 | Nov 10, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $68 | $20.94 | +224.74% | 18 | Nov 10, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | $10 → $8 | $1.11 | +620.72% | 13 | Nov 10, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $4 | $0.807 | +395.66% | 7 | Nov 9, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $56 | $38.61 | +45.04% | 9 | Nov 9, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $107.48 | +33.05% | 6 | Nov 5, 2026 | |
| SABS SAB Biotherapeutics | Reiterated: Buy | $11 | $3.00 | +266.67% | 3 | Nov 5, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $52 | $30.15 | +72.47% | 6 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $97 → $119 | $99.37 | +19.75% | 4 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $5.22 | +302.30% | 13 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $9.50 | +247.37% | 6 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $151 | $36.44 | +314.38% | 12 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $13.80 | +23.19% | 7 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $156 | $89.55 | +74.20% | 1 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $97 | $18.57 | +422.35% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $61 | $33.28 | +83.29% | 16 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.00 | +366.67% | 19 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.63 | +574.85% | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $11.73 | -48.85% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4.25 | $4.19 | n/a | 8 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $5 | $1.87 | n/a | 9 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 → $4 | $9.28 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.7 → $0.75 | $0.000001 | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $130 | $23.47 | n/a | 1 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $7 | $3.07 | n/a | 2 | Jul 21, 2021 |
Sana Biotechnology
Nov 17, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $1.88
Upside: +485.11%
Wave Life Sciences
Nov 12, 2026
Reiterated: Buy
Price Target: $19 → $15
Current: $2.87
Upside: +422.65%
argenx SE
Nov 10, 2026
Reiterated: Buy
Price Target: $1,232
Current: $950.95
Upside: +29.55%
Beam Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $68
Current: $20.94
Upside: +224.74%
Cabaletta Bio
Nov 10, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $1.11
Upside: +620.72%
Allogene Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $4
Current: $0.807
Upside: +395.66%
Roivant Sciences
Nov 9, 2026
Reiterated: Buy
Price Target: $56
Current: $38.61
Upside: +45.04%
Rhythm Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $143
Current: $107.48
Upside: +33.05%
SAB Biotherapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $11
Current: $3.00
Upside: +266.67%
Agios Pharmaceuticals
Oct 28, 2026
Reiterated: Buy
Price Target: $52
Current: $30.15
Upside: +72.47%
Oct 21, 2026
Reiterated: Buy
Price Target: $97 → $119
Current: $99.37
Upside: +19.75%
Oct 14, 2026
Reiterated: Buy
Price Target: $21
Current: $5.22
Upside: +302.30%
Oct 6, 2026
Reiterated: Buy
Price Target: $33
Current: $9.50
Upside: +247.37%
Oct 5, 2026
Reiterated: Buy
Price Target: $151
Current: $36.44
Upside: +314.38%
Sep 17, 2026
Reiterated: Buy
Price Target: $17
Current: $13.80
Upside: +23.19%
Sep 4, 2026
Initiated Coverage: Buy
Price Target: $156
Current: $89.55
Upside: +74.20%
Aug 10, 2026
Reiterated: Buy
Price Target: $97
Current: $18.57
Upside: +422.35%
Jun 30, 2026
Reiterated: Buy
Price Target: $57 → $61
Current: $33.28
Upside: +83.29%
Jun 30, 2026
Reiterated: Buy
Price Target: $14
Current: $3.00
Upside: +366.67%
Mar 23, 2026
Reiterated: Buy
Price Target: $11
Current: $1.63
Upside: +574.85%
Mar 20, 2026
Reiterated: Sell
Price Target: $6
Current: $11.73
Upside: -48.85%
Nov 11, 2025
Reiterated: Hold
Price Target: $5 → $4.25
Current: $4.19
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $15 → $5
Current: $1.87
Upside: n/a
Jun 3, 2024
Initiated Coverage: Buy
Price Target: $6 → $4
Current: $9.28
Upside: n/a
May 18, 2023
Reiterated: Hold
Price Target: $1.7 → $0.75
Current: $0.000001
Upside: n/a
May 11, 2023
Rated: Buy
Price Target: $130
Current: $23.47
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $16 → $7
Current: $3.07
Upside: n/a